FSD Pharma Inc.
HUGE · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $571 | $2,742 | $2,354 | $3,084 |
| - Cash | $3 | $1 | $3 | $4 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $568 | $2,741 | $2,352 | $3,081 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$2 | -$2 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$2 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.079 | -0.048 | -0.043 | -0.029 |
| % Growth | -63.5% | -11.4% | -49.1% | – |
| Operating Cash Flow | -$1 | -$2 | -$1 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$2 | -$1 | -$2 |